Pharmacokinetics of Rifabutin in Japanese HIV-Infected Patients with or without Antiretroviral Therapy

OBJECTIVE: Based on drug-drug interaction, dose reduction of rifabutin is recommended when co-administered with HIV protease inhibitors for human immunodeficiency virus (HIV)-associated mycobacterial infection. The aim of this study was to compare the pharmacokinetics of rifabutin administered at 30...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanuma, Junko, Sano, Kazumi, Teruya, Katsuji, Watanabe, Koji, Aoki, Takahiro, Honda, Haruhito, Yazaki, Hirohisa, Tsukada, Kunihisa, Gatanaga, Hiroyuki, Kikuchi, Yoshimi, Oka, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734254/
https://www.ncbi.nlm.nih.gov/pubmed/23940604
http://dx.doi.org/10.1371/journal.pone.0070611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734254/
https://www.ncbi.nlm.nih.gov/pubmed/23940604
http://dx.doi.org/10.1371/journal.pone.0070611

Ejemplares similares